About Dr. Zhu Jianhong
Dr. Zhu Jianhong (朱剑虹) is one of China's most distinguished neurosurgeons and the Director of the Department of Neurosurgery at Zhongshan Hospital, affiliated with Fudan University. He holds the title of Chief Physician and Professor and is nationally recognized as a leading authority on brain tumor surgery, cerebrovascular surgery, and minimally invasive neurosurgical techniques.
Over a career spanning more than three decades, Dr. Zhu has established Zhongshan Hospital's Neurosurgery Department as one of the premier brain surgery centers in Shanghai. He is particularly renowned for his expertise in glioma surgery, cerebral aneurysm treatment, and skull base surgery — areas where his technical precision and high-volume experience have earned him a national reputation.
International patients with brain tumors, cerebrovascular disease, or other neurosurgical conditions consistently identify Dr. Zhu as one of Shanghai's top neurosurgeons for both primary surgical treatment and expert second opinions.
Professional Positions and Affiliations
- Director, Department of Neurosurgery, Zhongshan Hospital, Fudan University
- Vice Chairman, Chinese Society of Neurosurgery
- Chairman, Brain Tumor Committee, Chinese Society of Neurosurgery
- Editorial Board Member: Journal of Neurosurgery, Neurosurgery, Chinese Journal of Neurosurgery
- Fellow, Congress of Neurological Surgeons (CNS)
- Fellow, European Association of Neurosurgical Societies (EANS)
Specialties and Clinical Expertise
- Glioma Surgery — awake craniotomy with intraoperative language and motor mapping for eloquent cortex tumors; fluorescence-guided surgery (5-ALA) for high-grade glioma; intraoperative MRI-guided resection; supramaximal resection for IDH-mutant gliomas; coordination with neuro-oncology for temozolomide and bevacizumab therapy
- Cerebral Aneurysm Treatment — microsurgical clipping for ruptured and unruptured aneurysms; complex aneurysm surgery (giant, fusiform, posterior circulation); coordination with interventional neuroradiology for endovascular coiling and flow diversion
- Skull Base Surgery — acoustic neuroma (vestibular schwannoma) with hearing preservation; meningioma resection (convexity, skull base, petroclival); craniopharyngioma; chordoma and chondrosarcoma; endoscopic endonasal approaches for pituitary and anterior skull base tumors
- Brain Metastases — surgical resection for symptomatic or large metastases; coordination with radiation oncology for stereotactic radiosurgery (SRS) and whole brain radiation
- Cerebrovascular Malformations — arteriovenous malformation (AVM) resection; cavernous malformation surgery; moyamoya disease bypass surgery
- Hydrocephalus — endoscopic third ventriculostomy (ETV); ventriculoperitoneal shunt; normal pressure hydrocephalus management
- Spinal Neurosurgery — spinal cord tumor resection; intramedullary tumor surgery with intraoperative neuromonitoring
Academic and Research Contributions
Dr. Zhu Jianhong has published over 160 peer-reviewed papers in leading international neurosurgery journals, with a particular focus on glioma surgery outcomes, awake craniotomy techniques in Chinese patients, and the surgical management of skull base tumors. His research on the safety and efficacy of awake craniotomy for eloquent cortex gliomas in Chinese patients — demonstrating equivalent oncological outcomes with significantly better neurological preservation compared to surgery under general anesthesia — has been widely cited and has contributed to the adoption of this technique at major Chinese neurosurgery centers.
He chairs the Brain Tumor Committee of the Chinese Society of Neurosurgery and is a Fellow of both CNS and EANS. He is a regular invited speaker at CNS, EANS, and the World Federation of Neurosurgical Societies (WFNS) congresses.
Hospital: Zhongshan Hospital Neurosurgery Department
Under Dr. Zhu's leadership, Zhongshan Hospital's Neurosurgery Department operates:
- An Intraoperative MRI Suite for real-time tumor resection guidance
- An Awake Craniotomy Program with dedicated neuropsychology and speech therapy support
- A Fluorescence-Guided Surgery Program (5-ALA) for high-grade glioma
- A Multidisciplinary Neuro-Oncology Tumor Board integrating neurosurgery, neuro-oncology, radiation oncology, and neuroradiology
- A Stereotactic Radiosurgery Program (Gamma Knife) for brain metastases, acoustic neuromas, and meningiomas
- A Cerebrovascular Surgery Program with 24/7 capability for ruptured aneurysm clipping
Why International Patients Choose Dr. Zhu Jianhong
- China's leading brain tumor surgeon — Chairman of China's national brain tumor surgery committee
- Awake craniotomy expertise — language and motor preservation for eloquent cortex tumors
- Intraoperative MRI capability — real-time guidance for maximal safe resection
- CNS and EANS Fellow — internationally credentialed and aligned with global neurosurgery standards
- Complex skull base surgery — acoustic neuroma, meningioma, and craniopharyngioma at the highest technical level
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Zhongshan Hospital, 180 Fenglin Road, Xuhui District, Shanghai
- Appointment Lead Time: 2″4 weeks for elective consultations; urgent cases expedited through CMCS
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Pre-consultation: Overseas MRI, CT, and pathology reports reviewed remotely through CMCS before travel
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking neurosurgical care with Dr. Zhu Jianhong at Zhongshan Hospital. Our services include priority appointment booking, medical record and imaging translation, remote pre-consultation review, on-site interpretation, accommodation coordination, insurance liaison, and post-surgical follow-up with your home country neurologist or neuro-oncologist.
📧 Contact us: contract@medicalsh.com
💬 WeChat: gezhanglao
🌐 medicalsh.com
0 commenti